Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1/ LU0959058974 /
| NAV20/06/2024 | Chg.0.0000 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 16.0000CHF | 0.00% | reinvestment | Equity Worldwide | Franklin Templeton ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | - | - | - | - | - | - | 9.21 | -5.68 | 6.68 | 3.26 | - |
| 2014 | 11.87 | 6.56 | -9.89 | -7.23 | 2.91 | 8.08 | -0.85 | 12.98 | -2.20 | 8.09 | 1.11 | 1.80 | +35.10% |
| 2015 | 5.06 | 5.66 | 3.02 | -5.36 | 9.64 | 0.16 | 1.97 | -9.81 | -12.55 | 6.08 | 4.36 | -0.96 | +4.80% |
| 2016 | -22.92 | -6.42 | 4.01 | 3.46 | 6.14 | -7.69 | 9.91 | -1.80 | 5.29 | -11.03 | 8.47 | -3.54 | -19.54% |
| 2017 | 5.32 | 7.54 | -1.39 | 0.34 | -7.16 | 8.65 | 2.45 | 4.53 | 0.74 | -8.11 | -1.14 | 2.84 | +13.94% |
| 2018 | 5.53 | -3.18 | -2.96 | -3.12 | 4.73 | 0.78 | 1.75 | 3.95 | -1.84 | -15.19 | 2.95 | -11.88 | -19.01% |
| 2019 | 13.32 | 4.59 | -0.69 | -5.52 | -2.78 | 11.65 | -4.78 | -5.51 | -5.76 | 10.63 | 10.40 | 3.05 | +28.84% |
| 2020 | -4.98 | 0.46 | -9.25 | 13.61 | 9.74 | 2.98 | 0.28 | 0.00 | 2.43 | -4.36 | 11.43 | 3.31 | +25.79% |
| 2021 | 0.05 | 1.25 | -6.48 | 0.63 | -5.63 | 5.63 | -5.12 | 4.72 | -4.83 | -1.56 | -7.59 | -0.18 | -18.40% |
| 2022 | -9.89 | -3.68 | 4.60 | -8.86 | -6.83 | 2.79 | 2.71 | -0.60 | -1.67 | 4.09 | 6.23 | -4.12 | -15.66% |
| 2023 | 4.59 | -5.08 | 0.29 | 3.44 | -3.89 | 0.96 | 2.41 | -1.28 | -3.68 | -6.06 | 3.59 | 18.69 | +12.38% |
| 2024 | 4.54 | 8.00 | -1.95 | -7.32 | 1.52 | -0.44 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 18.70% | 19.69% | 18.82% | 22.13% | 25.00% |
| Ratio de Sharpe | 0.23 | 1.15 | 0.49 | -0.41 | -0.08 |
| Le meilleur mois | +18.69% | +18.69% | +18.69% | +18.69% | +18.69% |
| Le plus défavorable mois | -7.32% | -7.32% | -7.32% | -9.89% | -9.89% |
| Perte maximale | -14.37% | -14.37% | -14.37% | -39.78% | -47.73% |
| Surperformance | +5.57% | - | +7.27% | -2.57% | -19.41% |
Toutes les cotations dans CHF
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Franklin Templeton Investment Fu... | reinvestment | 46.2800 | +17.52% | -7.09% | |
| Franklin Templeton Investment Fu... | reinvestment | 26.3800 | +17.93% | -4.94% | |
| Franklin Templeton Investment Fu... | reinvestment | 43.2700 | +19.73% | +5.56% | |
| Franklin Templeton Investment Fu... | reinvestment | 40.0000 | +19.15% | -4.60% | |
| F.Biotechnology Dis.Fd.F USD | reinvestment | 12.8100 | +17.09% | -8.17% | |
| F.Biotechnology Dis.Fd.N-H1 PLN | reinvestment | 9.6700 | +17.64% | - | |
| Franklin Templeton Investment Fu... | reinvestment | 64.5000 | +19.20% | -3.01% | |
| Franklin Templeton Investment Fu... | reinvestment | 24.4000 | +16.80% | -9.56% | |
| F.Biotechnology Dis.Fd.W USD | reinvestment | 20.1500 | +19.16% | -3.17% | |
| F.Biotechnology Dis.Fd.Z USD | reinvestment | 15.1400 | +18.75% | -3.99% | |
| Franklin Templeton Investment Fu... | reinvestment | 33.5500 | +17.35% | -7.55% | |
| Franklin Templeton Investment Fu... | reinvestment | 16.0000 | +12.91% | -15.25% | |
| F.Biotechnology Dis.Fd.A-H1 EUR ... | reinvestment | 11.8400 | +15.85% | -11.84% | |
| Franklin Templeton Investment Fu... | reinvestment | 40.5500 | +18.22% | -5.43% |
Performance
| CAD | +3.69% | ||
|---|---|---|---|
| 6 Mois | +12.36% | ||
| 1 An | +12.91% | ||
| 3 Ans | -15.25% | ||
| 5 Ans | +8.77% | ||
| 10 ans | +23.93% | ||
| Depuis le début | +60.00% | ||
| Année | |||
| 2023 | +12.38% | ||
| 2022 | -15.66% | ||
| 2021 | -18.40% | ||
| 2020 | +25.79% | ||
| 2019 | +28.84% | ||
| 2018 | -19.01% | ||
| 2017 | +13.94% | ||
| 2016 | -19.54% | ||
| 2015 | +4.80% | ||
